CorMedix, Inc.
(NYSE Amex Equities : CRMD)

( )
CRMD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.03%107.820.6%$510.44m
ABTAbbott Laboratories
-0.72%84.290.8%$387.86m
TMOThermo Fisher Scientific Inc.
-0.07%278.071.0%$373.04m
ALGNAlign Technology, Inc.
1.46%178.976.3%$343.54m
ISRGIntuitive Surgical, Inc.
-0.20%500.272.4%$284.80m
BDXBecton, Dickinson and Company
0.66%255.041.1%$282.07m
EWEdwards Lifesciences Corporation
-2.36%216.551.2%$230.35m
SYKStryker Corporation
-0.32%218.321.3%$229.33m
ZBHZimmer Biomet Holdings, Inc.
-0.26%137.071.7%$204.67m
BSXBoston Scientific Corporation
0.28%42.671.1%$202.86m
BAXBaxter International Inc.
-0.16%87.171.7%$190.95m
DXCMDexCom, Inc.
0.68%174.378.3%$167.88m
ABMDABIOMED, Inc.
-0.20%195.443.3%$158.48m
WATWaters Corporation
-0.10%209.984.0%$115.30m
IDXXIDEXX Laboratories, Inc.
-0.38%279.883.7%$110.11m

Company Profile

CorMedix, Inc. operates as a pharmaceutical and medical device company, which seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The firm is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.